Multiparametric MRI for Assessing Breast Cancer Response to Anti-HER2 Therapy
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL
Conditions: HER2-positive Breast Cancer
Interventions: DEVICE: MRI|DRUG: Trastuzumab
Sponsor: University of Washington